Paul Moore

Direttore Tecnico/Scientifico/R&S presso ZYMEWORKS INC.

Patrimonio netto: 59 746 $ in data 30/04/2024

58 anni

Health Technology

Consumer Services

Health Services

Posizioni attive di Paul Moore

Società	Posizione	Inizio	Fine
ZYMEWORKS INC.	Direttore Tecnico/Scientifico/R&S	01/07/2022	-
Zymeworks BC, Inc. Zymeworks BC, Inc. BiotechnologyHealth Technology Zymeworks BC, Inc. is a clinical-stage biopharmaceutical company engaged in the discovery, development, and commercialization of biotherapeutics. Its product, ZW25 and ZW49, are a bispecific antibody that cans two non-overlapping epitopes. The company was founded by Anthony Fejes, J. Haig deB Farris, Nick Bedford, Ali Tehrani and Andrew S. Wright on September 8, 2003 and is headquartered in Vancouver, Canada.	Direttore Tecnico/Scientifico/R&S	18/07/2022	-

Società	Posizione	Inizio	Fine
MACROGENICS, INC.	Corporate Officer/Principal	01/04/2008	01/07/2022
Celera Corp. Celera Corp. Medical/Nursing ServicesHealth Services Celera Corp. provides medical diagnostics services. It offers disease management solutions through a combination of tests and services based on genetics discovery platforms. Celera was founded in 1998 and is headquartered in Alameda, CA.	Corporate Officer/Principal	01/05/2005	01/04/2008
Human Genome Sciences, Inc. Human Genome Sciences, Inc. Medical SpecialtiesHealth Technology Human Genome Sciences, Inc. is a biopharmaceutical company that exists to place new therapies into the hands of those battling serious disease. Its lead products include BENLYSTA for systemic lupus erythematosus and raxibacumab for inhalation anthrax. The firm's other products include, mapatumumab, darapladib, albiglutide, ZALBIN, HGS1036 and HGS1029. The company was founded by Alan G. Walton and William A. Haseltine in 1992 and is headquartered in Gaithersburg, MD.	Corporate Officer/Principal	-	-

University of Strathclyde	Undergraduate Degree
University of Glasgow	Doctorate Degree

Distribuzione geografica

Posizioni

Corporate Officer/Principal	3
Chief Tech/Sci/R&D Officer	2
Undergraduate Degree	1

Settori

Posizioni ricoperte

Attive

Inattive

Società quotate in Borsa

Aziende private

Società quotate in Borsa	2
MACROGENICS, INC.	Health Technology
ZYMEWORKS INC.	Health Technology

Aziende private	3
Human Genome Sciences, Inc. Human Genome Sciences, Inc. Medical SpecialtiesHealth Technology Human Genome Sciences, Inc. is a biopharmaceutical company that exists to place new therapies into the hands of those battling serious disease. Its lead products include BENLYSTA for systemic lupus erythematosus and raxibacumab for inhalation anthrax. The firm's other products include, mapatumumab, darapladib, albiglutide, ZALBIN, HGS1036 and HGS1029. The company was founded by Alan G. Walton and William A. Haseltine in 1992 and is headquartered in Gaithersburg, MD.	Health Technology
Celera Corp. Celera Corp. Medical/Nursing ServicesHealth Services Celera Corp. provides medical diagnostics services. It offers disease management solutions through a combination of tests and services based on genetics discovery platforms. Celera was founded in 1998 and is headquartered in Alameda, CA.	Health Services
Zymeworks BC, Inc. Zymeworks BC, Inc. BiotechnologyHealth Technology Zymeworks BC, Inc. is a clinical-stage biopharmaceutical company engaged in the discovery, development, and commercialization of biotherapeutics. Its product, ZW25 and ZW49, are a bispecific antibody that cans two non-overlapping epitopes. The company was founded by Anthony Fejes, J. Haig deB Farris, Nick Bedford, Ali Tehrani and Andrew S. Wright on September 8, 2003 and is headquartered in Vancouver, Canada.	Health Technology